| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/22/2010 | WO2010043711A1 Allosteric protein kinase modulators |
| 04/22/2010 | WO2010043592A1 Lipase inhibitors for use for the treatment of obesity |
| 04/22/2010 | WO2010043584A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 04/22/2010 | WO2010043311A1 Method for producing spirocyclic tetronic acid derivatives |
| 04/22/2010 | WO2010043148A1 2-cyano-3-(substituted) amino-3-phenyl acrylic ester compound, preparing method and use thereof |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | US20100099895 Process for one-stage preparation of 2-methyltetrahydrofuran from furfural over a catalyst |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099682 Acetylene derivatives |
| 04/22/2010 | US20100099550 Homogeneous Process for the Hydrogenation of Carboxylic Acids and Derivatives Thereof |
| 04/22/2010 | US20100099042 Polymerizable anion-containing sulfonium salt and polymer, resist composition, and patterning process |
| 04/22/2010 | US20100098634 Imaging Agents Useful for Identifying AD Pathology |
| 04/22/2010 | DE102008051690B3 Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten Process for the preparation of spirocyclic Tetronsäurederivaten |
| 04/22/2010 | CA2740783A1 Sphingosine-1-phosphate receptor antagonists |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 04/21/2010 | EP2177510A1 Allosteric protein kinase modulators |
| 04/21/2010 | EP2177505A1 Bicyclic acylguanidine derivative |
| 04/21/2010 | EP2176255A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 04/21/2010 | EP2027102B1 PRODUCTION OF PHTHALIC ANHYDRIDE BY GAS PHASE OXIDATION OF o-XYLOL IN A PRIMARY AND A SECONDARY REACTOR |
| 04/21/2010 | EP1694661B1 Process for the production of ethers |
| 04/21/2010 | CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 04/21/2010 | CN101696200A Endo-methylene hexahydrophthalic anhydride and production method thereof |
| 04/21/2010 | CN101696199A Preparation method of 4,4'-(Hexafluoroisopropylidene) diphthalic anhydride |
| 04/21/2010 | CN101696198A Preparation method of 2,5-dimethyl-4-oxhydryl-3(2H) furanone |
| 04/21/2010 | CN101696197A Iodine-phenyl-substituted cyclic cetoenols |
| 04/21/2010 | CN101696196A Method for increasing furfural yield and recovering methanol |
| 04/21/2010 | CN101696184A Iodine-phenyl-substituted cyclic cetoenols |
| 04/21/2010 | CN101531650B Novel partial condensation process for reclaiming maleic anhydride from gas containing same |
| 04/20/2010 | US7700808 1-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 04/20/2010 | US7700802 Method of separating stereoisomers of dicarboxylic acid having norbornene or norbornane structure, or derivative thereof |
| 04/20/2010 | US7700788 Catalytic selective production of furandicarboxylic acid and/or formylfuran carboxylic acid |
| 04/20/2010 | US7700772 Amino heterocyclic modulators of chemokine receptor activity |
| 04/20/2010 | US7700658 Administering 3-[[3-(4-chloro-3-ethylphenoxy)phenyl][[3-(1,1,2,2- tetrafluoroethoxy)phenyl]-methyl]amino]- 1,1,1-trifluoro-2-propanol(ylgucpd25); anticholesterol agents to increase the level of high density lipoproteins; atherosclerosis; coronary artery; strokes, cardiovasculardiseases; dyslipidemia |
| 04/20/2010 | US7700648 5-benzyl-3-furylmethyl 1R-trans-2,2-dimethyl-3-((E)-2-cyano-3-ethoxy-3-oxo-1-propenyl)cyclopropanecarboxylate; pesticides; controlling pests |
| 04/20/2010 | US7700645 Comprising the ethanolate solvate of Prezista" aka darunavir ethanolate; improved pharmacokinetics;stability; bioavailability; purity; industrial scale; viricides |
| 04/20/2010 | US7700632 3-(3-Chloro-biphenyl-4-yloxymethyl)-benzoic acid; antidiabetic; type 2 diabetes, insulin resistance, impaired glucose tolerance, obesity |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700522 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 04/20/2010 | CA2418744C Novel aminocyclohexane derivatives |
| 04/15/2010 | WO2010041271A2 Process for preparation of (s)-n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4-b]furan-8-yl)ethyl] propionamide and novel intermediates thereof |
| 04/15/2010 | WO2010041269A1 Process for preparation of mycophenolic acid, its salt and ester derivatives |
| 04/15/2010 | WO2010041162A1 Tetrahydrofuranyl sulfonamides for use as ampa modulators in the treatment of cns disorders |
| 04/15/2010 | WO2010040843A2 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds |
| 04/15/2010 | WO2010040261A1 Process for preparing 2-alkyl-3-aroyl-5-nitro-benzofurans |
| 04/15/2010 | WO2010002209A3 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 04/15/2010 | WO2009030467A8 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 04/15/2010 | US20100094028 METHODS FOR THE PREPARATION OF HEXAHYDROFURO[2,3-b]FURAN-3-OL |
| 04/15/2010 | US20100093828 Compounds for the treatment of proliferative disorders |
| 04/15/2010 | US20100093694 Compounds for the Treatment of Hepatitis C |
| 04/15/2010 | DE102008046898A1 Verfahren und Anlage zur Gewinnung fester Reaktionsprodukte aus Lösungen Method and apparatus for recovering solid reaction products from solutions |
| 04/15/2010 | CA2739559A1 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof |
| 04/15/2010 | CA2737092A1 Process for preparing 2-alkyl-3-aroyl-5-nitro-benzofurans |
| 04/14/2010 | EP1934194B1 Anti-malarial compound isolated from gomphostemma niveum |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/14/2010 | CN101693857A Preparation method of optical pure gamma/delta-lactone spice |
| 04/14/2010 | CN101693723A 3-tri-alkoxy phenyl dialkyl phosphine tetrafluoroborate and synthesis and application thereof |
| 04/14/2010 | CN101693704A Method for synthesizing optically-active trans-Whiskey lactone |
| 04/14/2010 | CN101157674B Method for purifying citalopram salt |
| 04/13/2010 | US7696379 Acetylene derivatives |
| 04/13/2010 | US7696365 Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitors |
| 04/13/2010 | US7696360 Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-L-gulonic acid |
| 04/13/2010 | US7696357 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders |
| 04/13/2010 | US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 04/13/2010 | US7696186 7,9-substituted tetracycline compounds |
| 04/13/2010 | US7695980 Chemiluminescent compounds and their use |
| 04/13/2010 | US7695736 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/13/2010 | CA2392016C Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
| 04/08/2010 | WO2010038029A1 New process for preparing diketones and medicaments |
| 04/08/2010 | WO2010037760A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 04/08/2010 | WO2010037536A1 N-protected guanidine-substituted furans, thiophenes, and pyrrols as cysteine protease inhibitors |
| 04/08/2010 | WO2010037210A1 Viral polymerase inhibitors |
| 04/08/2010 | US20100087665 Method for continuously producing 2,5-dihydrofuran |
| 04/08/2010 | US20100087664 Preparation of citalopram and salts thereof |
| 04/08/2010 | US20100087663 Polynary metal vanadium oxide phosphate |
| 04/08/2010 | US20100087430 Novel benzofuran potassium channel blockers and uses thereof |
| 04/08/2010 | US20100087320 Arylphenyl-substituted cyclic keto-enols |
| 04/08/2010 | US20100084971 Material for organic electroluminescence device and electroluminescence device employing the same |
| 04/07/2010 | EP2172534A1 Light-emitting device material and light-emitting device |
| 04/07/2010 | EP2172460A1 Compositions useful as inhibitors of JAK and other protein kinases |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | CN101691364A Method for synthesizing 4-fluorin-2(5 hydrogen) furanone |
| 04/07/2010 | CN101220012B Method for synthesizing polysubstitution 4-fluorine-2(5H)-furanone |
| 04/07/2010 | CN101157048B A high performance vanadium phosphorus oxygen catalyst with nanostructure as well as its preparing method |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7692006 Phthalazinone derivatives |
| 04/06/2010 | US7691903 Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
| 04/06/2010 | US7691900 nervous system disorders; by reducing activation of the microglia an/or astrocytes and/or by reducing reactive gliosis; |
| 04/06/2010 | US7691884 Heterocyclic sulfonamide inhibitors of β amyloid production |
| 04/06/2010 | CA2513738C Casr antagonist |
| 04/06/2010 | CA2416220C Preparation of phosphatase inhibitors |
| 04/01/2010 | WO2010035228A1 Method for producing phenolphthalein using a heteropolyacid catalyst |
| 04/01/2010 | WO2010034827A1 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions |
| 04/01/2010 | WO2010034512A1 Compounds with antimalarial activity |
| 04/01/2010 | WO2009151299A3 Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereof |
| 04/01/2010 | WO2009148654A3 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 04/01/2010 | WO2009130387A3 A process for preparation of formate salt |
| 04/01/2010 | US20100081833 Hydroxymethylfurfural ethers and esters prepared in ionic liquids |
| 04/01/2010 | US20100081831 Method for producing phenolphthalein compound using ionic liquid catalyst composition |